Early benefits of pravastatin to experimentally induced atherosclerosis

Journal of Cardiovascular Pharmacology

Volumn 39, Issue 3, 2002, Pages 389-395

  Silva, Eliane P ^a   Fonseca, Francisco A H ^a   Ihara, Silvia S M ^a   Izar, Maria C O ^a   Lopes, Ieda L ^a   Pinto, Leonor E S A ^a   Badimon, Juan J ^a   Tuffik, Sergio ^a   Paiva, Therezinha B ^a   Kasinski, Nelson ^a   De Paola, Angelo V ^a   Carvalho, Antonio C C ^a  

^a Cardiology Division   (Brazil)

Author keywords

Atherosclerosis; Endothelium; Experimental; Lipids; Pravastatin

Indexed keywords

ACETYLCHOLINE; CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PRAVASTATIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA ATHEROSCLEROSIS; ARTERY ENDOTHELIUM; ARTICLE; ATHEROSCLEROTIC PLAQUE; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL DIET; CHOLESTEROL LIVER LEVEL; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; DOSE RESPONSE; DRUG EFFICACY; FAT CONTENT; HISTOPATHOLOGY; LOW FAT DIET; MALE; NONHUMAN; PRIORITY JOURNAL; RABBIT; STAGING; THORACIC AORTA; TREATMENT OUTCOME;

ACETYLCHOLINE; ANIMALS; ANTICHOLESTEREMIC AGENTS; AORTA, THORACIC; CHOLESTEROL; CORONARY ARTERIOSCLEROSIS; DIET, ATHEROGENIC; ENDOTHELIUM, VASCULAR; IMMUNOHISTOCHEMISTRY; MALE; MUSCLE, SMOOTH, VASCULAR; NITROPRUSSIDE; PRAVASTATIN; RABBITS; TIME FACTORS; TUNICA INTIMA; TUNICA MEDIA; VASODILATION; VASODILATOR AGENTS;

EID: 0036178089     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-200203000-00010     Document Type: Article

References (28)

1. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels
2. Influence of pravastatin and plasma lipids on clinical events in the West of Scotland Coronary Prevention Study (WOSCOPS)
3. Lipoprotein changes and reduction in the incidence of major coronary heart disease events in the Scandinavian Simvastatin Survival Study (4S)
4. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels
5. Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes. The MIRACL study: A randomized controlled trial
6. Thrombosis and acute coronary-artery lesions in sudden cardiac ischemic death
7. Stability and instability: Two faces of coronary atherosclerosis. The Paul Dudley White Lecture 1995
8. Integrated regulation of pressure and flow in the coronary microcirculation
9. Nitric oxide activity in the human coronary circulation: Impact of risk factors for coronary atherosclerosis
10. Impact of coronary risk factors on contribution of nitric oxide and adenosine to metabolic coronary vasodilation in humans
11. Nitric oxide reversibly inhibits the migration of cultured vascular smooth cells
12. Dietary magnesium improves endothelial dependent relaxation of balloon injured arteries in rats
13. Chronic endothelial dysfunction after oversized coronary balloon angioplasty in pigs: A 12-week follow-up of coronary vasoreactivity in vivo and in vitro
14. Atherosclerosis: An inflammatory disease
15. Cholesterol reduction rapidly improves endothelial function after acute coronary syndromes: The RECIFE (Reduction of Cholesterol in Ischemia and Function of the Endothelium) trial
16. Should reductase inhibitor therapy to lower cholesterol be instituted in the setting of an acute coronary event?
17. A simple method for the isolation and purification of total lipids from animal tissue
18. A definition of initial, fatty streak and intermediate lesions of atherosclerosis. A report from the committee on vascular lesions of the council on arteriosclerosis, American Heart Association
19. Effects of low-dose pravastatin sodium on plasma cholesterol levels and aortic atherosclerosis of heterozygous WHHL rabbits fed a low cholesterol (0,03%) enriched diet for one year
20. Comparative studies on tissue cholesterol
21. -)
22. Differential efficacy of vasodilators in hypercholesterolaemic rabbits
23. Pravastatin has cholesterol-lowering independent effects on the artery wall of atherosclerotic monkeys
24. Effects of lipid lowering by pravastatin on progression and regression of coronary artery disease in symptomatic men with normal to moderately elevated serum cholesterol levels. The Regression Growth Evaluation Statin Study (REGRESS)
25. Rapid reversal of endothelial dysfunction in hypercholesterolaemic rabbits treated with simvastatin and pravastatin
26. Pravastatin sodium activates endothelial nitric oxide synthase independent of its cholesterol-lowering actions
27. Vascular effects of HMG CoA-reductase inhibitors (statins) unrelated to cholesterol lowering: New concepts for cardiovascular disease
28. Dietary lipid lowering reduces tissue factor expression in rabbit atheroma